Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of nontoxic lipid A and endotoxin on resistance of mice to Toxoplasma gondii.
Journal of biological response modifiers·1988
Glycolipid induced proliferation of lipopolysaccharide hyporesponsive C3H/HeJ splenocytes.
Journal of leukocyte biology·1988
Characterization of a nontoxic monophosphoryl lipid A.
Reviews of infectious diseases·1987
The adjuvant properties of a nontoxic monophosphoryl lipid A in hyporesponsive and aging mice.
Journal of biological response modifiers·1987
Enhancement of chemiluminescence and phagocytic activities by nontoxic and toxic forms of lipid A.
Journal of biological response modifiers·1986
Effect of monophosphoryl lipid A on host resistance to bacterial infection.
Infection and immunity·1986
Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.
Journal of biological response modifiers·1990
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.
Journal of biological response modifiers·1990
Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
Journal of biological response modifiers·1990
Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Journal of biological response modifiers·1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.
Journal of biological response modifiers·1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.
Journal of biological response modifiers·1990
Structural and functional analysis of peptidyl-tRNA hydrolase 2 from Candidatus Lokiarchaeum sp. GC14_75.
Acta crystallographica. Section F, Structural biology communications·2026
Ibrutinib tablet splitting as a practical strategy for dose reduction in the management of drug-drug interactions.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026